The pilot study of the features of HIV-1 resistant variants spread using molecular clusters
Dublin Core | PKP Metadata Items | Metadata for this Document | |
1. | Title | Title of document | The pilot study of the features of HIV-1 resistant variants spread using molecular clusters |
2. | Creator | Author's name, affiliation, country | Alina A. Kirichenko; Central Research Institute for Epidemiology; Россия |
2. | Creator | Author's name, affiliation, country | Dmitry E. Kireev; Central Research Institute for Epidemiology; Россия |
2. | Creator | Author's name, affiliation, country | Yulia N. Sidorina; Oryol AIDS Center; Россия |
2. | Creator | Author's name, affiliation, country | Natalia D. Abashina; Oryol AIDS Center; Россия |
2. | Creator | Author's name, affiliation, country | Elena E. Brusentseva; Oryol AIDS Center; Россия |
2. | Creator | Author's name, affiliation, country | Vasily G. Akimkin; Central Research Institute for Epidemiology; Россия |
3. | Subject | Discipline(s) | |
3. | Subject | Keyword(s) | HIV-1; drug resistance; resistance mutations; antiretroviral therapy; molecular clusters; transmission clusters; surveillance; genomic surveillance |
4. | Description | Abstract | Introduction. As a result of routine testing of HIV-1 drug resistance (DR), a significant amount of viral nucleotide sequences and epidemiological data of HIV-infected individuals have been collected. Combined with the increasing use of bioinformatics methods in practice, it has become possible to study the features of HIV-1 resistant variants spread using molecular clustering analysis. The aim of the study was to validate the molecular clustering analysis in a pilot region of Russia using a significant number of nucleotide sequences to study the features of the spread of HIV-1 resistant variants. Materials and methods. HIV-1 nucleotide sequences were obtained from 899 HIV-infected patients who were registered at the Oryol AIDS Center in 2016–2021. HIV-1 genetic variants were determined using the Stanford University database, REGA and HIV BLAST. Resistance mutations and prognostic HIV-1 DR were determined using the Stanford University database. Phylogenetic analysis was carried out using the MEGA program. HIV-1 molecular clusters were identified using Cluster Picker software. Results. In the pilot region, sub-subtype A6 dominated (85.7%); an increase in the share of CRF63_02A6 was noted. HIV-1 resistance was found in 13.6% of patients without antiretroviral therapy (ART) experience and in 52.0% with ART experience. Molecular clusters were more often formed by HIV-1 nucleotide sequences from ART-naïve patients. HIV-1 DR variants were less likely to fall into molecular clusters. The sources of transmitted mutations were more often patients with ART experience. The most actively and efficiently transmitted mutations were K103N, V179E/T, Y181C and G190S, associated with virus resistance to efavirenz and nevirapine. |
5. | Publisher | Organizing agency, location | Central Research Institute for Epidemiology |
6. | Contributor | Sponsor(s) |
|
7. | Date | (DD-MM-YYYY) | 18.11.2024 |
8. | Type | Status & genre | Peer-reviewed Article |
8. | Type | Type | Research Article |
9. | Format | File format | |
10. | Identifier | Uniform Resource Identifier | https://microbiol.crie.ru/jour/article/view/18680 |
10. | Identifier | Digital Object Identifier (DOI) | 10.36233/0372-9311-565 |
10. | Identifier | eLIBRARY Document Number (EDN) | dsxqmo |
11. | Source | Title; vol., no. (year) | Journal of microbiology, epidemiology and immunobiology; Vol 101, No 5 (2024) |
12. | Language | English=en | en |
13. | Relation | Supp. Files |
Fig. 4. Clusters with transmitted resistance mutations. The triangle indicates HIV-1 nucleotide sequences from ART-experienced patients, and the circle indicates HIV-1 nucleotide sequences from ART-naïve patients. HIV-1 nucleotide sequences from patients with the earliest date of diagnosis of HIV infection in the cluster are marked in light grey. (257KB) Fig. 1. Distribution of HIV-1 genetic variants by year of diagnosis of HIV infection. (829KB) Fig. 2. Prevalence and level of HIV-1 drug resistance among ART-naïve patients. (383KB) Fig. 3. Prevalence and level of HIV-1 drug resistance among ART-experienced patients. (505KB) |
14. | Coverage | Geo-spatial location, chronological period, research sample (gender, age, etc.) | |
15. | Rights | Copyright and permissions |
Copyright (c) 2024 Kirichenko A.A., Kireev D.E., Sidorina Y.N., Abashina N.D., Brusentseva E.E., Akimkin V.G.![]() This work is licensed under a Creative Commons Attribution 4.0 International License. |